Health Management Resources
This page supports the objectives of the Correctional Officers Health and Safety Act of 1998, which requires that the Attorney
General and the Secretary of Health and Human Services provide guidelines for infectious disease prevention, detection,
and treatment of inmates and correctional employees who face exposure to infectious diseases in correctional facilities.
Interim Ebola Protocol
Inmate Screening and Management (December 2014)View Protocol
Clinical Practice Guidelines
The BOP's Clinical Practice Guidelines (CPGs) are made available to the public for informational purposes only. The Bureau does not make any promise or warrant these guidelines for any other purpose, and assumes no responsibility for any injury or damage resulting from the reliance thereof. Proper medical practice necessitates that all cases be evaluated on an individual basis and that treatment decisions be patient-specific.
- Anticoagulation Protocol (2013)
- Antimicrobial Stewardship (2013)
- Asthma (2013)
- Depression (2014)
- Detoxification of Chemically Dependent Inmates (2014)
- Diabetes (2012)
- Headache (2003)
- Hepatitis A (2008)
- Hepatitis B (2011)
- Hepatitis C - Current Treatment Regimens (Sofosbuvir, Simeprevir) (2014)
- Hepatitis C - Previously Approved Treatment Regimens (Boceprevir, Telaprevir, Interferon) (2014)
- Lice Protocol (2014)
- Management of Food Allergies (2012)
- Management of HIV (2013)
- Managing STDs in the Correctional Setting: A Guide for Clinicians, 2nd Ed (2011)
- Medical Management of Exposures: HIV, HBC, HCV, Human Bites and Sexual Assaults (2014)
- Medical Management of Malnutrition (Undernutrition) (2014)
- Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections (2012)
- Nutrition Management After Bariatric Surgery (2013)
- Ophthalmology Guidance (2008)
- Prevention and Management of Acute and Chronic Wounds. (2014)
- Preventive Dentistry: Oral Disease Risk Management Protocols (2012)
- Preventive Health Care (2013)
- Scabies Protocol (2014)
- Seasonal Influenza Guidance (2013)
- Sexually Transmitted Disease Treatment Tables (2011)
- Tuberculosis (2010) & Addendum: INH-Rifapentine Treatment for Latent TB Infection (2014)
- Varicella Zoster Virus Infections (2011) & Varicella Timeline Calculator (2011)
Infection with MRSA has long been associated with exposure to a health care environment, particularly the inpatient hospital setting. Recent reports, however, indicate that new MRSA strains have evolved that are affecting previously healthy persons throughout the world without direct or indirect contact with health care facilities.
Within the federal prison system, community-onset MRSA infections have been associated with illicit, unsanitary tattoo practices and poor inmate hygiene. MRSA transmission in other correctional systems has been linked to inmates sharing towels, linens, or other personal items potentially contaminated by wound drainage, as well as inmates lancing their own boils or other inmates' boils with fingernails or tweezers.
MRSA infections often present as mild skin or soft tissue infections, such as furuncles, that occur spontaneously without an obvious source. Inmates with MRSA skin infections commonly complain of an infected pimple, an insect bite, a spider bite, or a sore. Many MRSA infections cause minor inflammation without pain and infected inmates may not seek medical attention.
BOP Health Services National Formulary
Last updated 2014
The BOP formulary is a list of medications that are considered by our professional staff to ensure high quality, cost-effective drug therapy for the population served. Participants of the Pharmacy, Therapeutics, and Formulary Meeting are responsible for the development, maintenance, and submission of recommendations on the formulary for approval to the BOP Medical Director. Periodically, medications are reassessed and extensively reviewed for inclusion, exclusion, or restrictions in the formulary as applicable per current evidence-based practices and security concerns. Regular maintenance of the BOP formulary ensures optimal treatment options are uniformly consistent and readily available.
The primary goals of BOP Formulary Management are to optimize therapeutic outcomes, maximize cost effectiveness of medications, and ensure prescribed drug usage is fully appropriate given the correctional environment.
BOP Pandemic Influenza Plan
Last updated October 2012
An influenza pandemic can occur when a non-human (novel) influenza virus gains the ability for efficient and sustained human-to-human transmission and then spreads globally. The following modules outline the BOP's plan to minimize illness and deaths during an influenza pandemic, while continuing to maintain operations.
Clinical Guidelines for Discharge Assistance
Information to assist Social Workers and other health care providers in discharge planning services, for inmates who will be transitioning from institutional life to the community.View Guidelines
BOP Report on Infectious Disease Management
Our administrative policies and clinical guidelines for the medical management of infectious diseases.View Report